We aim to transform patient care with non-invasive neural sensors.
Our goal is to create a positive global impact through the development and implementation of novel human brain monitoring solutions.
By developing new ways to monitor and study the brain, we have the potential to revolutionise patient care and advance our current understanding of it, enabling better diagnostics and treatment for complex neurological conditions.
The brain is the most critical organ, controlling all other bodily functions, yet it is one of the least understood and most complex parts of the body.
Gaining a better understanding of the brain unlocks the opportunity for significant medical advances, only some of which we currently understand. CoMind’s technology not only has the power to improve the lives of patients, but it also has the potential to unlock new insights into and understanding of the brain and its functions. This has the potential to change the way we approach brain health and technology, and ultimately, to make a lasting impact on society.
30 Under 30 – Europe – Technology (2022)
James Dacombe, a Thiel Fellow, dropped out of high school at age 16 to work as a software engineer at a startup and then left that to build CoMind at 17. The London-based, neurotechnology startup, which has raised $15 million, aims to develop a neurosensing technology that would catalyze a new wave of neuroscience and neurology applications within medical devices.
CoMind Welcomes New Leaders to the Team
CoMind is thrilled to announce the addition of two new leaders to the team. Mimosa (“Mo”) Nguyen has been appointed as the Director of People, and Allie Childs as the Director of Product. Both will play instrumental roles in the strategic direction of CoMind and our continued growth.
Stay in touch
Get regular updates about our latest hires, technical and business milestones, and developments in brain-computer interface technology by subscribing